Abstract
Oral anticoagulation management is developing outside the traditional hospital setting, primarily because of increased indications for anticoagulation treatment including nonrheumatic atrial fibrillation. 1 2 One Birmingham study has shown that nurse led primary care anticoagulation clinics can be developed, with international normalised ratio (INR) measurement determined by near patient testing. 1 This model would be suitable for most primary health care settings in many countries.
While several near patient test systems are available for INR estimation, it is important that the INR can be measured reliably within primary care settings, given the diYculties already established with laboratory standardisation. [3] [4] [5] Three near patient test devices-Protime (ITC Technidyne), Coaguchek (Boehringer Mannheim) and TAS (Diagnostic Testing)-have been shown to be robust and reliable in comparison with standard laboratory INR techniques. [6] [7] [8] In this study we compared these three near patient test coagulometers for INR estimation in a primary care setting. We report the results obtained on venous blood samples using the three systems, in addition to a sample sent to the local reference laboratory. The local reference laboratory (Queen Elizabeth Hospital, Birmingham) used an ACL 2000 system with IL reagent, and was taken as the gold standard for the study. The laboratory performs consistently within consensus in the national external quality assessment scheme (NEQAS) anticoagulation assessment. Although a true gold standard does not exist, the laboratory was used as the criterion to judge the validity of the three near patient test systems in this study in terms of realistic performance expectations, attention to preanalytical sample handling, and personnel requirements. The objectives of the study were to evaluate the reliability in terms of INR measurement of three near patient testing machines; to evaluate any technical diYculties encountered; to compare the costs of the near patient test machines; and to compare the quality assurance procedures for each machine.
Methods
The study was based in one primary care anticoagulation clinic in an inner city general practice. The clinic was managed by a practice nurse with previous near patient test experience. Patients attending the clinic who had been receiving warfarin for at least six months were eligible for the study. Housebound patients were excluded. Patients were asked to participate and to consent to the venous samples required for the three near patient tests. They were informed that warfarin management would be based on the same near patient tests consistently (Coaguchek). The evaluation was performed following the criteria determined by the near patient testing working party of the British Society of Haematology, including samples across the whole therapeutic INR range, with samples from patients not receiving warfarin and samples above the upper limit of the therapeutic range. 9 
PROCEDURE
+ The three near patient test systems were prepared and test cards, reagent strips, and cuvettes held at room temperature for 10 minutes before use. + Internal quality control (QC) was performed on the Coaguchek (CK) and TAS machines with control material supplied by the manufacturers, and the Protime was switched on to "self check and calibrate."
+ Five millilitres of venous whole blood were taken, and a drop immediately added to the Coaguchek test strip followed by the Protime cuvette. The remainder was added to a citrated bottle and mixed well. A drop of citrated blood was then added to the TAS test card and the remainder sent to the reference laboratory for analysis. + All INR results were recorded centrally.
Parallel INR estimation was performed on the diVerent near patient tests at each weekly anticoagulation clinic from July to December 1997. Paired t tests, regression analysis, and Bland-Altman plots were undertaken to investigate the agreement between the results obtained between the three near patient test systems and the laboratory, although not all methods are reported. The results were also analysed to determine the number of times dose adjustment would have been made depending on whether near patient test values or the laboratory INR value were used.
Results
Nineteen patients (including two not taking warfarin) provided 62 samples for analysis. INR results ranged from 0.8 to 8.2 overall, and 1.0 to 5.7 based on the laboratory method. Taking the laboratory method as the gold standard, 12 of the 62 results were < 2.0 and six were >4.5. The largest proportion of patients were receiving warfarin treatment for atrial fibrillation (47%), followed by mitral valve replacement (26%). Approximately 50% of patients were under 65 years of age.
INR COMPARISONS
There were no statistical or clinically significant diVerences in terms of correlation coeYcients (fig 1) or Bland-Altman plots (fig 2) between results from the three systems, although all near patient tests showed slightly higher mean readings than the laboratory ( Table 2 describes the three near patient test systems used in the evaluation, in terms of how the specimen is collected and measured, the quantity and type of blood used for the collection, the reagent properties, and the quality control and calibration methods. No mechanical problems were encountered with any of the machines, and robustness had previously been evaluated for all of them. [6] [7] [8] All three near patient test systems were simple and user friendly. The Protime system takes longer to produce a result (up to six minutes), as this includes quality control procedures integral to the test, whereas the other machines require a QC procedure before patient testing begins. The Coaguchek and TAS require only a small quantity of blood and therefore with capillary sampling there is less risk of an inadequate sample. The amount of blood required by the Protime is quite substantial (65 µl) and previous results. They also have the capability to link to both a printer and computerised decision support software. Protime oVers a graphical display of patient results within therapeutic range for patients performing home monitoring, which gives a clearer idea of their INR control. TAS oVers a menu option for operator identity so that aberrant results can be traced to the operator. It has memory capability for up to 1000 previous results. All three systems oVer at least a 12 month warranty and a service contract, with a promise of a replacement machine. Both Coaguchek and Protime are small and lightweight with the facility to be battery operated for increased portability. TAS, in contrast, is heavier and therefore less appropriate for domiciliary use.
Discussion

INR COMPARABILITY
Three systems previously validated in laboratory conditions were assessed for use in a nonlaboratory setting. The INR results showed no significant disagreement between the systems. Agreement was shown for all therapeutic ranges although, as shown in other studies, 10 11 as absolute INR increases results become more diverse, with near patient test results considerably higher. This was shown consistently in all three systems. Given that management is clinically based under these circumstances, this was not a clinically important finding. DiVerent dosing decisions would have been made on around 20% of occasions. This compares favourably with interlaboratory comparisons, where up to 50% of results would suggest different dose decisions.
12
All three near patient test systems are therefore safe and eYcient for producing acceptable and reproducible INR results within the therapeutic range in a primary care setting. All three systems, however, were subject to operator dependent variables at the time of blood letting. Adequate training in both capillary blood sampling, specific use of the machines, and quality assurance procedures is therefore essential.
CONCLUSIONS
The three instruments used in this study showed good correlation within the therapeutic ranges, were easy to operate, and required little sample preparation or instrument maintenance. They are all, therefore, appropriate for 
